Ryo Itabashi Selected Research

Ryo Itabashi Research Topics

21	Stroke (Strokes) 06/2023 - 10/2008
14	Ischemic Stroke 06/2023 - 12/2011
5	Cerebral Hemorrhage 01/2022 - 10/2008
5	Atrial Fibrillation 01/2020 - 08/2015
4	Hematoma 01/2022 - 05/2009
3	Infarction (Infarctions) 01/2023 - 01/2013
3	Transient Ischemic Attack 03/2021 - 01/2018
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 05/2009
3	Embolism (Embolus) 01/2021 - 01/2018
3	Hemorrhage 12/2018 - 05/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024 - 08/2015
2	Thrombosis (Thrombus) 02/2022 - 10/2020
2	Hyperglycemia 01/2021 - 01/2020
2	Intracranial Embolism 08/2015 - 01/2014
2	Pathologic Constriction (Stenosis) 12/2011 - 02/2011
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2024
1	Diabetes Mellitus 10/2022
1	Coma (Comas) 10/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 02/2022
1	Hemiplegia (Spastic Hemiplegia) 02/2022
1	Hemianopsia (Bitemporal Hemianopsia) 10/2021
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2021
1	Acute Coronary Syndrome 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Peripheral Arterial Disease 01/2020
1	Rupture 01/2020
1	Venous Thromboembolism 01/2020
1	Infections 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Thromboembolism 08/2015
1	Thrombocytopenia (Thrombopenia) 08/2015
1	Embolic Stroke 01/2014
1	Heart Diseases (Heart Disease) 01/2014
1	Liver Diseases (Liver Disease) 01/2010
1	Putaminal Hemorrhage 05/2009

6	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2023 - 08/2019
4	AnticoagulantsIBA 01/2021 - 01/2011
4	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 01/2010
3	Antihypertensive Agents (Antihypertensives)IBA 10/2019 - 10/2008
2	Nicardipine (Dagan)FDA LinkGeneric 01/2022 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 10/2021 - 01/2021
2	Cilostazol (Pletal)FDA LinkGeneric 01/2021 - 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	fibrin fragment D (D-dimer)IBA 01/2023
1	C-Type Lectins (C-Type Lectin)IBA 01/2023
1	Cytochrome P-450 CYP2C19IBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 03/2021
1	Purinergic P2Y Receptor AntagonistsIBA 03/2021
1	Clopidogrel (Plavix)FDA Link 03/2021
1	GadoliniumIBA 02/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	SodiumIBA 10/2019
1	fasudil (AT 877)IBA 10/2019
1	ozagrelIBA 10/2019
1	LipidsIBA 12/2018
1	Heparin (Liquaemin)FDA LinkGeneric 08/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2011
1	Prothrombin (Factor II)IBA 01/2011

5	Therapeutics 08/2021 - 10/2008
3	Thrombectomy 01/2023 - 10/2022
3	Carotid Endarterectomy 01/2021 - 01/2020
1	Early Ambulation 10/2022
1	Length of Stay 10/2022
1	Massage (Zone Therapy) 02/2022
1	Endarterectomy (Thromboendarterectomy) 01/2021
1	Percutaneous Coronary Intervention 01/2020
1	Secondary Prevention 01/2018
1	Catheter Ablation 08/2015
1	Catheters 08/2015
1	Punctures 08/2015
1	Stents 02/2011